Ya Li

Ya Li

Auto-generated profile, based on publicly available information

Ya Li

Yantai Jiahui Biotech Co., Ltd., Yantai 264003, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2022 in Marine Drugs
Verified
Journal Article
Open access
PDF file
RLRun-Ze Liu
Run-Ze Liu
Wenjun LiWenjun Li
Wenjun Li
JZJuan-Juan Zhang
Juan-Juan Zhang
ZLZheng-Yi Liu
Zheng-Yi Liu
YLYa Li
Ya Li
SQSong Qin
Song Qin
Phycocyanin is an excellent antioxidant with anti-inflammatory effects on which recent studies are growing; however, its specific target remains unclear. Linear tetrapyrrole compounds such as bilirubin have been shown to lead to the induction of heme oxygenase 1 expression in vivo, thus achieving antioxidant and anti-inflammatory effects. Phycocyanin is bound internally with linear tetrapyrrole phycocyanobilin in a similar structure to bilirubin. We speculate that there is probably a way of inducing the expression of heme oxygenase 1, with which tissue oxidative stress and inflammation can be inhibited, thus inhibiting pulmonary fibrosis caused by oxidative damage and inflammation of lung. By optimizing the enzymatic hydrolysis process, phycocyanobilin-bound phycocyanin peptide were obtained, and its in vitro antioxidant, anti-inflammatory, and anti-pulmonary fibrosis activities were investigated. The results show that the phycocyanobilin peptide was able to alleviate oxidative and inflammatory damage in cells through the Keap1-Nrf2-HO-1 pathway, which in turn relieved pulmonary fibrosis symptoms.